Tokyo, Japan

Koichi Watashi

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Sentry Therapeutics Limited. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Koichi Watashi. Retrieved from https://idiyas.com/inventor/koichi-watashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Koichi Watashi: Innovator in Pharmaceutical Macrocycles**

Introduction

Koichi Watashi, an accomplished inventor based in Tokyo, Japan, has made significant contributions to the field of pharmaceuticals through his innovative work on macrocycles. With a focus on cyclic compounds, his research has the potential to advance medical therapies and improve health outcomes.

Latest Patents

Koichi holds one patent related to his invention of macrocycles. The patent concerns cyclic compounds represented by the general formula (I), wherein R, R', and R'' are defined within the specifications. These cyclic compounds have promising applications in pharmaceuticals, positioning Watashi as a pivotal figure in pharmaceutical innovation.

Career Highlights

Throughout his career, Koichi Watashi has established himself as a key member of Sentry Therapeutics Limited, a company dedicated to advancing therapeutic solutions. His expertise in the development of innovative compounds has played a crucial role in driving the company's research initiatives forward.

Collaborations

Koichi often collaborates with esteemed colleagues including Michael Robert Peel and Andrew Scribner. Working alongside such talented individuals has fostered a creative environment where groundbreaking ideas can flourish and lead to impactful inventions.

Conclusion

As a dedicated inventor, Koichi Watashi continues to contribute substantially to the pharmaceutical industry through his innovative work on macrocycles. His patent serves as a testament to the importance of collaboration and research in driving forward the boundaries of medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…